More Imugene Ltd news Imugene LtdASX: IMU Oncolytic Virotherapy CF33 Patent Granted in Japan Jan 31, 2022 at 4:13 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
